Study Set Content:
a determination of the least costly among alternative interventions that are assumed to produce equivalent outcomes
Cost-minimization analysis (CMA):
a comparison of costs in monetary units with outcomes in quantitative non-monetary units, e.g., reduced mortality or morbidity
Cost-effectiveness analysis (CEA
a form of costeffectiveness analysis that compares costs in monetary units with outcomes in terms of their utility, usually to the patient, measured
Cost-utility analysis (CUA):
a form of cost-effectiveness analysis that presents costs and outcomes in discrete categories, without aggregating or weighing them
Cost-consequence analysis (CCA):
compares costs and benefits, both of which are quantified in common monetary units
Cost-benefit analysis (CBA):
determines the impact of implementing or adopting a particular technology or technology-related policy on a designated budget, e.g., of a drug formulary or health plan.
Budget-impact analysis (BIA)
Current Environment
Total population- Target population- Resources utilization- Cost of illness
Key factors total population
Incidence/prevalence
Key factors Target population
Current treatments
Resources utilization Key factors
Unit costs
IMPACT ON
Disease incidence
New diagnosis
Additonal therapies
Additional procedures
Hospitilizations
New Environment
Current environment nga may new
Difference=
Budget Impact
least cost alternative is chosen
Cost-minimization analysis (CMA)
goal is to identify, eamine and compare the relevant costs and consequences of competing drug regimens and interventions • costs are expressed in monetary units
Cost-effectiveness analysis (CEA)
consequences are measure in their natural units such as– • decision maker in identifying a preferrred choice of possible alternatives
cases cured – lives saved – hospitalization prevented
Cost-effectiveness analysis (CEA) result expressed as:
cost per unit of success
cost-effectiveness ratio (CER)=
cost / effectiveness
choice is that of
lower ratio
all costs (inputs) and benefits (consequences) of alternatives expressed in monetary terms
cost-benefit analysis (CBA
